Pfizer Ltd has announced that the Delhi High Court at the hearing held on March 21, 2016 extended the interim injunction suspending the operation of Notification dated March 10, 2016 banning the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup till the next date of hearing.
With reference to the earlier letter dated March 14, 2016 regarding Interim Injunction on the prohibition of manufacture and sale of "Corex", Pfizer Ltd has announced that the Delhi High Court at the hearing held on March 21, 2016 was pleased to extend the interim injunction suspending the operation of the Notification dated March 10, 2016 banning the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup till the next date of hearing.
The company is awaiting the order from the Honourable Delhi High Court in this respect.
The company is awaiting the order from the Honourable Delhi High Court in this respect.
The scrip opened at Rs. 1689 and has touched a high and low of Rs. 1689 and Rs. 1659.6 respectively. So far 6988(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 7621.11 crore.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2724 on 22-Sep-2015 and a 52 week low of Rs. 1611 on 21-Mar-2016. Last one week high and low of the scrip stood at Rs. 1821 and Rs. 1611 respectively.
The promoters holding in the company stood at 63.92 % while Institutions and Non-Institutions held 12.86 % and 23.22 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment